As announced by Exor (“Exor” or the “Company”) on 29 July 2022, the Company’s board of directors has approved the transfer of the listing of the Company’s ordinary shares (ISIN NL0012059018) to Euronext Amsterdam, a regulated market organised and managed by Euronext Amsterdam N.V., which hosts some of Europe’s leading corporations, and as announced by Exor on 3 August 2022, the Company has received approval by the Euronext Listing Board of the admission to listing and trading of the Company’s ordinary shares on Euronext Amsterdam.
Further to this, Exor hereby announces receipt today of written approval by the Dutch Authority for the Financial Markets (the “AFM”) of the prospectus relating to the admission to listing and trading of the Company’s ordinary shares on Euronext Amsterdam. The prospectus is available on Exor’s website at https://exor.com/pages/exor-prospectus-admission-listing-and-trading.
The trading of Exor’s ordinary shares on Euronext Amsterdam is expected to commence on 12 August 2022 at 9:00 Central European Time (CET).
